Viewing Study NCT02180061


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-04-18 @ 10:33 AM
Study NCT ID: NCT02180061
Status: COMPLETED
Last Update Posted: 2020-03-31
First Post: 2014-07-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)
Sponsor:
Organization: